BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,756,000 | +40.0% | 476,978 | +19.2% | 2.27% | +85.8% |
| Q4 2021 | $5,540,000 | +278.2% | 400,001 | +292.3% | 1.22% | +229.4% |
| Q3 2021 | $1,465,000 | -73.7% | 101,961 | -71.0% | 0.37% | -69.5% |
| Q2 2021 | $5,565,000 | +123.7% | 351,961 | +43.8% | 1.22% | +110.9% |
| Q1 2021 | $2,488,000 | -38.0% | 244,680 | -54.6% | 0.58% | -43.9% |
| Q4 2020 | $4,011,000 | +45.8% | 538,370 | -32.8% | 1.03% | +41.2% |
| Q3 2020 | $2,751,000 | -35.9% | 800,740 | -11.1% | 0.73% | -39.8% |
| Q2 2020 | $4,291,000 | +115.5% | 900,608 | -9.5% | 1.21% | +31.0% |
| Q1 2020 | $1,991,000 | -49.4% | 995,608 | -12.8% | 0.92% | -18.8% |
| Q4 2019 | $3,937,000 | – | 1,141,212 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |